Zeotech Limited
Zeotech Limited (ZEO.AX) Financial Performance & Income Statement Overview
Analyze Zeotech Limited (ZEO.AX) financial statements (income, balance sheet, and cash flow) across both yearly and quarterly periods.
Zeotech Limited (ZEO.AX) Income Statement & Financial Overview
Access detailed annual and quarterly income data for Zeotech Limited ZEO.AX financial performance.
Metric | Q2 2025 | Q4 2024 | Q2 2024 | Q4 2023 |
---|---|---|---|---|
Revenue | $931155.00 | $45386.00 | $729736.00 | $12658.00 |
Cost of Revenue | $0.00 | $0.00 | $201456.00 | $87546.00 |
Gross Profit | $931155.00 | $45386.00 | $528280.00 | -$74888.00 |
Gross Profit Ratio | $1.00 | $1.00 | $0.72 | -$5.92 |
R&D Expenses | $404484.00 | $450212.00 | $601048.00 | $234349.00 |
SG&A Expenses | $1.50M | $1.13M | $2.06M | $1.69M |
Operating Expenses | $1.90M | $1.58M | $2.66M | $1.69M |
Total Costs & Expenses | $1.90M | $1.58M | $2.66M | $1.78M |
Interest Income | $0.00 | $0.00 | $81510.00 | $25315.00 |
Interest Expense | $0.00 | $0.00 | $44316.00 | $19211.00 |
Depreciation & Amortization | $89915.00 | $22078.00 | $100728.00 | $87546.00 |
EBITDA | -$972516.00 | -$1.61M | -$1.93M | -$1.67M |
EBITDA Ratio | -$1.04 | -$35.47 | -$2.64 | -$133.75 |
Operating Income | -$972516.00 | -$1.53M | -$1.93M | -$1.78M |
Operating Income Ratio | -$1.04 | -$33.74 | -$2.64 | -$140.66 |
Other Income/Expenses (Net) | -$136888.00 | -$161648.00 | -$7.11M | $6104.00 |
Income Before Tax | -$1.11M | -$1.69M | -$3.84M | -$1.77M |
Income Before Tax Ratio | -$1.19 | -$37.30 | -$5.26 | -$140.18 |
Income Tax Expense | $0.00 | $0.00 | -$1.36M | $4.00 |
Net Income | -$1.11M | -$1.69M | -$3.84M | -$1.77M |
Net Income Ratio | -$1.19 | -$37.30 | -$5.26 | -$140.18 |
EPS | -$0.001 | -$0.001 | -$0.002 | -$0.001 |
Diluted EPS | -$0.001 | -$0.001 | -$0.002 | -$0.001 |
Weighted Avg Shares Outstanding | $1.85B | $1.68B | $1.74B | $1.71B |
Weighted Avg Shares Outstanding (Diluted) | $1.85B | $1.68B | $1.74B | $1.71B |
Over the last four quarters, Zeotech Limited achieved steady financial progress, growing revenue from $12658.00 in Q4 2023 to $931155.00 in Q2 2025. Gross profit stayed firm with margins at 100% in Q2 2025 versus -592% in Q4 2023. Operating income totaled -$972516.00 in Q2 2025, maintaining a -104% margin over recent quarters. Despite shifts in R&D and SG&A costs, EBITDA stayed strong at -$972516.00. Net income rose to -$1.11M, with EPS at -$0.001. Disciplined expense strategies and efficient operations ensured sustained profitability and long-term financial stability.
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan